We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Huaizhong Health Group Inc (CE) | USOTC:ADAD | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.11 | 0.00 | 01:00:00 |
|
ADAIAH DISTRIBUTION INC.
|
(Exact name of registrant as specified in its charter)
|
Large accelerated filer
|
¨
|
Accelerated filer
|
¨
|
Non-accelerated filer
|
¨
|
Smaller reporting company
|
x
|
(Do not check if a smaller reporting company)
|
Emerging growth company
|
¨
|
|
|
2 |
|
|
|
Three Months
Ended
January 31,
2020
|
|
|
Three Months
Ended
January 31,
2019
|
|
||
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
||
|
|
|
|
|
|
|
||
Operating Expenses
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
General and Administrative
|
|
|
5,318 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Expenses
|
|
|
5,318 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Expense (related party)
|
|
|
115 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (Loss) for the Period
|
|
|
5,433 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (Loss) Per Share
|
|
|
|
|
|
|
|
|
(Basic and Diluted)
|
|
|
0.0000 |
|
|
|
0.0000 |
|
|
|
|
|
|
|
|
|
|
Weighted Number of Average Shares outstanding
|
|
|
207,141,189 |
|
|
|
102,141,189 |
|
3 |
|
|
|
Three months
ended
January 31,
2020
|
|
|
Three months
ended
January 31,
2019
|
|
||
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
||
|
|
|
|
|
|
|
||
Net (Loss)
|
|
|
(5,433 |
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to reconcile Net Loss to net cash used in Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (Decrease) in accrued expenses
|
|
|
153 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in operating activities
|
|
|
(5,280 |
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans received from a related party
|
|
|
5,280 |
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided for by financing activities
|
|
|
5,280 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
Investing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (Decrease) in Cash
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash at the beginning of the period
|
|
|
|
|
|
|
|
|
Cash at the end of the period
|
|
|
0 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for income taxes
|
|
|
0 |
|
|
|
0 |
|
Cash paid for interest expense
|
|
|
0 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
Non Cash Transactions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
None
|
|
|
|
|
|
|
|
|
4 |
|
Period ending January 31 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
Additional paid
|
|
|
Accumulated
|
|
|
|
|
||||||
|
|
Shares
|
|
|
Common Stock
|
|
|
In Capital
|
|
|
Deficit
|
|
|
Total
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Balance October 31, 2018 (Audited)
|
|
|
102,141,118 |
|
|
|
43,859 |
|
|
|
102,141 |
|
|
|
(146,000 |
)
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) for the period ending January 31, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance January 31, 2019 (Unaudited)
|
|
|
102,141,118 |
|
|
|
43,859 |
|
|
|
102,141 |
|
|
|
(146,000 |
)
|
|
|
0 |
|
|
|
|
|
|
|
Additional paid
|
|
|
Accumulated
|
|
|
|
||||||||
|
|
Shares
|
|
|
Common Stock
|
|
|
In Capital
|
|
|
Deficit
|
|
|
Total
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Balance October 31, 2019 (Audited)
|
|
|
207,141,118 |
|
|
|
43,859 |
|
|
|
207,141 |
|
|
|
(272,097 |
)
|
|
|
(21,097 |
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) for the period ending January 31, 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,433 |
)
|
|
|
(5,433 |
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance January 31, 2020 (Unaudited)
|
|
|
207,141,118 |
|
|
|
43,859 |
|
|
|
207,141 |
|
|
|
(277,530 |
)
|
|
|
(26,530 |
)
|
5 |
|
6 |
|
7 |
|
8 |
|
9 |
|
10 |
|
11 |
|
12 |
|
13 |
|
Exhibit No.
|
|
Description
|
|
||
|
||
|
||
|
||
|
||
|
||
|
||
101
|
|
Interactive data files pursuant to Rule 405 of Regulation S-T
|
14 |
|
|
Adaiah Distribution Inc.
|
||
|
Registrant
|
||
|
|||
Date: March 10, 2020
|
By:
|
/s/ Yosef Yafe
|
|
|
Yosef Yafe
|
||
|
(Principal Executive Officer,
Principal Financial Officer,
Principal Accounting Officer & Sole Director)
|
15 |
1 Year Huaizhong Health (CE) Chart |
1 Month Huaizhong Health (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions